Dual-time-point FDG PET/CT imaging in prosthetic heart valve endocarditis by Scholtens, A.M. (Asbjørn M.) et al.
ORIGINAL ARTICLE
Dual-time-point FDG PET/CT imaging in
prosthetic heart valve endocarditis
A. M. Scholtens, MD,a L. E. Swart, MD,b H. J. Verberne, MD, PhD,c R. P. J. Budde,
MD, PhD,b and M. G. E. H. Lam, MD, PhDd
a Department of Nuclear Medicine, Meander Medical Center, Amersfoort, The Netherlands
b Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The
Netherlands
c Department of Radiology and Nuclear Medicine, Academic Medical Center, Amsterdam, The
Netherlands
d Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht,
The Netherlands
Received Mar 10, 2017; accepted Apr 12, 2017
doi:10.1007/s12350-017-0902-3
Purpose. FDG PET/CT has been of increasing interest in the diagnostic workup of pros-
thetic heart valve endocarditis (PVE). Some reports advocate later imaging time points to
improve the diagnostic accuracy for PVE. In this study, we compared standard and late FDG
PET/CT images in patients with a clinical suspicion of PVE.
Materials and Methods. Fourteen scans in 13 patients referred for FDG PET/CT for
suspicion of PVE performed at standard (60 min post injection) and late (150 min post injec-
tion) time points were scored based on visual interpretation and semi-quantitatively with
SUVmax and target-to-background ratio (TBR, defined as [SUVmax valve/SUVmean blood
pool]). Final diagnosis was based on surgical findings in all cases of infection (n 5 6) and
unremarkable follow-up in all others (n 5 8).
Results. Late images were more prone to false positive interpretation for both visual and
semi-quantitative analyses. Visual analysis of the standard images yielded 1 false negative and 1
false positive result. On the late images, no scans were false negative but 5 scans were false
positive.
Conclusion. Late FDG PET/CT imaging for PVE seems prone to false positive results.
Therefore, late imaging should be interpreted with caution. (J Nucl Cardiol 2017)
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Abbreviations
CTA Computed tomography angiography
FDG Fluorine-18 fluorodeoxyglucose
IQR Interquartile range
MBq Megabecquerel
PET Positron emission tomography
PHV Prosthetic heart valve
PVE Prosthetic heart valve endocarditis
SUV Standardized uptake value
TBR Target-to-background ratio
VOI Volume of interest
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INTRODUCTION
Prosthetic heart valve (PHV) implantation is per-
formed at an increasing rate, due to the prevalence of heart
valve disease increasing in tandemwith the growing aging
population, with over 800,000 annual procedures esti-
mated to be performed worldwide by the year 2050.1
Prosthetic heart valve (PHV) endocarditis (PVE) is a
relatively uncommon complication, with an incidence of
0.3-1.0% per patient per year,2 but is associated with an
alarmingly high mortality rate, especially when Staphy-
lococcus aureus is the pathogen involved.2,3 PVE can be
difficult to diagnose, with echocardiography unable to
identify signs of the disease in up to 30% of cases.4,5
Computed tomography angiography (CTA) of the
valve area has been shown to be of complementary
value to clinical routine workup in suspected PVE,6
although it can be difficult to distinguish between non-
infectious postoperative anatomical variation and infec-
tious complications in select cases.
Fluorine-18 fluorodeoxyglucose positron emission
tomography with CT-based attenuation correction (FDG
PET/CT) is gaining momentum as a tool in the diagnosis
of suspected PVE,7–10 due to its ability to image
inflammation activity as opposed to the aforementioned
modalities that image anatomy only. Recently, FDG
PET/CT was added as a diagnostic modality in the
guidelines of the European Society of Cardiology for the
diagnosis and management of infectious endocarditis.11
However, the optimal imaging protocol for FDG
PET/CT in PVE is still unclear, with preparatory
protocols and timing of image acquisition still subjects
of debate. In standard oncological FDG PET/CT proto-
cols, images are acquired 60 minutes after injection of
the tracer. However, for the detection of infection and
inflammation, both earlier and later imaging have been
proposed; the former based on the fast influx of glucose
into inflammatory cells followed by efflux based on
active glucose-6-phosphatase,12 the latter based on
persistent influx in inflammation and further clearance
of glucose from the blood pool leading to higher contrast
between activity in infectious foci and background.13
Based on earlier reports, delayed imaging may be of
additional value in diagnosing infection of cardiovascu-
lar implants.13,14 We performed both standard and
delayed acquisitions of FDG PET/CT images in a
number of patients referred for possible PVE under the
assumption that the delayed images may improve
diagnostic accuracy.
METHODS
Based on earlier reports,13,14 we added delayed acquisi-
tion at 150 minutes post injection of the radiotracer to our
clinical protocol for FDG PET/CT for suspicion of PVE, in
keeping with the innovation and development stages as
described by the IDEAL framework.15 Thirteen patients with
14 scans referred for FDG PET/CT with suspected PVE in the
University Medical Center Utrecht were imaged at standard
and late time points after giving informed consent. The local
ethical committee waived review of this study.
FDG PET/CT
All patients were prepared according to our protocol for
suppression of physiological myocardial glucose metabolism
(low-carbohydrate diet for 12 hours followed by a 12-hour fast
and 50 IU/kg heparin IV 15 minutes prior to FDG adminis-
tration).16 After injection of 2 MBq/kg FDG via an antecubital
vein, PET/CT images were acquired according to the standard
protocol at approximately 60 minutes and additionally of the
thorax at approximately 150 minutes post injection. All scans
were performed on the same FDG PET/CT system (Biograph
mCT, Siemens, Erlangen, Germany). Prior to the PET acqui-
sitions, non-contrast CT images were obtained for attenuation
correction (AC). PET images were obtained using 3D acqui-
sition, field of view 216 mm, and 3 minutes per bed position
scan time; low-dose CT acquisition for attenuation correction
was obtained with a pitch of 1.0, slice thickness 10 mm,
120 kV, and 40 mAs. PET/CT data were reconstructed using
ordered subset expectation maximization (OSEM) iterative
reconstruction (Gaussian filter, 4 iterations, 21 subsets).
All images were read on commercially available software
(Syngo.Via, Siemens, Erlangen, Germany). Volumes of Inter-
est (VOIs) were placed to ascertain semi-quantitative
measurements of glucose metabolism as follows:
– Automated growing VOI algorithm set to include pixels
within 40% of maximum measured standardized uptake
value (SUVmax) containing the PHV.
– VOI sphere within the lumen of the descending aorta
(maximum possible size without including vessel wall).
Care was taken to exclude non-suppressed myocardial
uptake and uptake in the aortic wall. From these VOIs, the
SUVmax in the region of the PHV and the mean standardized
uptake value (SUVmean) in the aortic blood pool were
obtained. Target-to-background ratios (TBR) were calculated
as SUVmax (PHV) divided by SUVmean (blood pool).8
Visual analysis was based on elevated uptake of FDG at
or near the implanted PHV, taking into account normal
variations and potential confounders.17 Elevated uptake at the
PHV or adjacent structures that exceeded that of the surround-
ing blood pool and could not be ascribed to a normal variant
was deemed suspect for PVE. Lesions on AC images were
confirmed on non-AC images to rule out possible AC artifacts.
Scoring was dichotomous into either no / unlikely PVE or
likely / certain PVE.
Diagnosis
The final diagnosis of infected versus uninfected PHV
was based on surgical findings in all cases of infection and
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based on unremarkable follow-up after clinically rejected
diagnosis of endocarditis (median 17.9 months, range 9.7-
22.6 months) in all others.
Analysis
Comparisons of means between the normally distributed
semi-quantitative values for infected and uninfected PHVs
were performed with paired Student’s t-test. Statistical anal-
yses were performed on Statistical Package for Social Sciences
(SPSS) software version 22. Additional ROC analysis was
performed with MedCalc software version 16.4.3.
RESULTS
Scans were performed for suspected PVE of one
mitral valve replacement, one pulmonic valve replace-
ment, and 11 aortic valve replacements. In two patients,
the aortic valve replacement was part of a Bentall graft
of the aortic root and ascending aorta. Median time from
implantation to FDG PET/CT was 654 days (range 21-
4992 days). Two patients were scanned within the first
six weeks after implantation. Standard images were
acquired at a mean of 65 minutes post injection (range
56-80 minutes), and late images were acquired at a mean
of 144 minutes post injection (range 120-195 minutes).
The time between standard and late scans ranged from
57 to 115 minutes. One patient was scanned twice: once
during antibiotic therapy to exclude other foci, and once
when cessation of antibiotic therapy led to an increase in
symptoms and the return of fever. Suppression of
physiological myocardial glucose metabolism was
acceptable in all but one patient. PVE was diagnosed
and surgically confirmed in 6 out of 13 patients. Patient
characteristics are listed in Table 1.
For the group as a whole, late images had signif-
icantly higher TBR values compared to the standard
images, due mostly to a decrease in measured activity in
the blood pool (SUVmax PHV standard 3.77 ± 1.06 vs.
late 4.30 ± 1.64, P = 0.02; TBR standard 2.55 ± 0.93
vs. late 4.27 ± 1.89, P = 0.0001).
Contingency tables for visual interpretation of
standard and late images are shown in Table 2. Sensi-
tivity, specificity, positive predictive value and negative
predictive value were 83%, 88%, 83%, and 88%
respectively for the standard images and 100%, 38%,
55%, and 100%, respectively, for late images. Although
late images correctly identified the single false negative
result in the standard images, false positive results
increased from 1 scan (7%) to 5 scans (36%).
Standard SUVmax in the region of the PHV was
higher in patients with PVE (median 4.13, interquartile
range [IQR] 3.42-4.69) than in those without (median
3.32, IQR 2.93-3.42), but not significantly so
(P = 0.12). The same was true for late SUVmax, but
with even more overlap between the values (PVE
median 4.20, IQR 3.52-6.20; non-PVE median 3.83,
IQR 3.02-4.24. P = 0.23). In two scans of patients with
PVE, the SUVs were comparatively low, probably due
to effective antibiotic therapy at the time of imaging
(based on normalized laboratory parameters and abated
symptoms); when these scans were excluded from the
analysis, standard SUVmax differed significantly
(P = 0.02), while the difference in late SUVmax was
still only trending towards significance (P = 0.07).
When patients under adequate antibiotic therapy were
regarded as a separate group, their values were more
comparable to those in the disease-free group (Figure 1).
Only the TBR at the standard acquisition time was
significantly different between infected and uninfected
PHVs (P = 0.027), with sensitivity, specificity, positive
predictive value, and negative predictive value of 83%,
88%, 83%, and 88%, respectively, at a threshold of 2.4
equalling the visual interpretation. Comparison of
receiver operating characteristic curves showed a greater
area under the curve for standard TBR (0.87) compared
to late TBR (0.79), although the difference was not
statistically significant (P = 0.22).
DISCUSSION
With the aim to improve our imaging protocol in
patients with suspected PVE, according to the IDEAL
criteria, we compared standard and late acquisition of
FDG PET/CT images in suspected PVE in a small
cohort of patients. The most important finding of our
study was that delayed images did not compare favor-
ably to standard images, as delayed images were more
prone to false positive results. Changes in SUVmax and
TBR between standard and late images showed great
variation in both the PVE group and the non-PVE group,
and almost complete overlap between the two groups.
Although delayed images did show a higher contrast
between target and background, due mostly to a
decrease in activity in the blood pool, this higher
contrast did not lead to better differentiation between
infected and uninfected PHVs.
These findings may indicate that even in uninfected
PHVs, a variable amount of sterile inflammation, likely
a mild foreign body reaction, is present which may be
indistinguishable from indolent or low-grade infection.
As no histological data were retrieved from any non-
infected PHVs, we cannot be certain about the under-
lying cause or why some PHVs show more inflammation
than others.
In two patients, standard FDG PET/CT showed very
low uptake of FDG around the PHV, even though both
patients were diagnosed with PVE (Table 1, patient 11
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and second scan of patient 13). However, both patients
were free of signs and symptoms and had normalized
laboratory parameters for infection after antibiotic
treatment at the time of PET/CT acquisition. It is likely
that FDG PET/CT showed the true effect of therapy in
these patients, as the subsequent and final diagnosis of
PVE was made at surgery after signs, symptoms, and
laboratory values had increased following cessation of
antibiotic therapy. As we have described earlier,18 an
initial response to antibiotic therapy does not necessarily
imply eradication of the causative pathogen. In one of
these two patients, the delayed images did show
increased uptake where the standard images did not,
but this also occurred in the late images of several
patients without PVE and should therefore be interpreted
with caution (Figure 2).
Conversely, standard PET/CT was false positive in
one patient, with high SUVmax and TBR values
compared to the other values in the uninfected group
(Table 1, patient 2). This scan was performed 4 weeks
after a Bentall procedure complicated by bleeding,
which necessitated a re-sternotomy to drain 400 ml of
haematoma and re-suturing of the graft. It is likely that
imaging relatively shortly after such a complicated
procedure visualized sterile inflammation as part of the
immune response to the haematoma. Delayed images
Figure 1. Semi-quantitative measurements. Values for standard SUVmax (A), late SUVmax (B),
changes in SUVmax from standard to late (DSUVmax, C) as well as standard and late Target-to-
background ratios (TBR) and changes in TBR (D, E, and F respectively) with boxplot
representations of median values, interquartile ranges, and total ranges. * Statistical outlier.
Table 2. Contingency tables of the visual analysis
Standard Late
PET/CT1 PET/CT2 PET/CT1 PET/CT2
PVE? 5 1 6 0
PVE- 1 7 5 3
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did not contribute to the differentiation of sterile
inflammation from infection.
These cases stress the importance of being well
informed about the patient history before interpreting
FDG PET/CT in patients with suspected PVE, as many
factors including details about the implantation, current
signs and symptoms, medication, and changes in
inflammatory laboratory parameters over time may
considerably influence the interpretation of findings.
In the other four scans with negative standard and
positive late images, two patients had positive blood
cultures with Staph. aureus and were receiving antibi-
otic treatment at the time of imaging, which could
potentially have led to false negative interpretation of
Figure 2. Examples of standard (top row) and late (bottom row) FDG PET/CT images in six
patients. A True positive uptake surrounding a mechanical aortic PHV in both phases. B True
negative images with hardly any uptake near the biological aortic PHV in either phase. C True
negative standard images with minimal uptake surrounding the mechanical mitral PHV, clearly
delineated in the late image. D True positive late phase with focal uptake near the strut of the
biological aortic PHV near the right coronary that is not apparent on standard images. Note
accumulation of uptake in mediastinal lymph nodes. E False positive late images with exaggerated
uptake near all struts of a biological aortic PHV with normal uptake on standard images. F False
positive uptake in both phases surrounding the prosthesis after semi-recent Bentall procedure
complicated by haematoma. Note the unsuppressed physiological uptake in the myocardium.
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the standard images. However, as both cases had well-
defined infectious foci elsewhere (presternal wound
infection in one and infected knee prosthesis in the
other) which were clearly visible on FDG PET/CT and
responded well to local therapy, PVE was not diagnosed
clinically and we believe it is more likely that the late
images were false positive. The other two patients had
negative blood cultures and were not receiving antibi-
otics, further corroborating that false positive late
images in the absence of PVE do occur.
Current opinion on the timeframe after surgery after
which FDG PET/CT can be reliably performed varies,
with indications that sterile postoperative inflammation
may persist as long as two months after surgery.10 In our
cohort, true negative images were obtained as early as
three weeks after surgery whereas false positive late
images occurred more than 13 years after implantation.
In our experience, scans may be performed as early as a
few weeks after uncomplicated surgery. If complications
occurred during or after surgery (as in the Bentall
procedure described above) sterile inflammation may
persist for longer.
In this study, only the standard TBR showed a
statistically significant difference between infected and
uninfected PHVs; standard SUVmax trended towards
but did not reach significance, likely due to the small
number of patients and the confounding factors men-
tioned above.
Defining threshold values on a cohort as small as
ours should be done with extreme caution, but TBR at
the standard acquisition time at a threshold of 2.4 did
perform as well as visual analysis, with equal sensitivity,
specificity, and positive and negative predictive values.
Perhaps of greater clinical value is the finding that all
scans with TBR[3.0 were infected. Still, some con-
founders such as surgical adhesive and lipomatous
hypertrophy of the interatrial septum show intense
uptake of FDG17 and would probably score above this
threshold, and our data show that scans performed under
adequate antibiotic therapy will be underestimated.
When comparing our data to the aforementioned
earlier reports, the case presented by Calderella et al.13
fits with our findings, basically mirroring the one case in
our series that was false negative on standard images
and true positive on late images (Figure 2D). However,
our data suggest that applying this approach to every
negative standard FDG PET/CT would lead to an
unwarranted number of false positive late scans. Lec-
cisotti et al.14 found added value for late images in
diagnosing cardiac implantable electronic device lead
infection, which is likely to have a different presentation
compared to PVE. False positive findings did occur for
lead infection, but did not increase on late images, as
opposed to our results in patients with PVE. Therefore,
these findings are not necessarily at odds with each
other. It may very well be that delayed images have
added value in diagnosing lead infection because of the
high false negative rate on standard images and the
apparent lack of physiologically increased uptake due to
sterile inflammation, as opposed to imaging in PVE.
Our findings are limited by the small amount of
patients included in a single center, and the retrospective
nature of the data. Ideally, our findings should be corrob-
orated by a prospective study powered for statistical
analysis. In these early stages of development of FDGPET/
CT protocols specifically applicable to PVE diagnosis, we
essentially find ourselves moving from stage 1 of the
IDEAL framework (Idea) to stage 2a (Development)where
the details about a new procedure become more defined.15
Regardless of its limitations, our data show a clinically
important risk of false positive PVE findings if late images
at 150minutes post injection are allowed toguide treatment
decisions, which should be taken into account in possible
future studies and their design. It is possible that the ideal
time point for FDG PET/CT imaging in PVE lies some-
where between our two chosen time points.
NEW KNOWLEDGE GAINED
Based on our current data, we cannot recommend
the use of delayed FDG PET/CT imaging in PVE,
whether as substitution for or as an adjunct to standard
images, as we believe the risk of false positive inter-
pretation is too high in either scenario.
CONCLUSION
Delayed imaging at 150 minutes post injection does
not seem to improve the interpretation of FDG PET/CT
in PVE as it seems prone to false positive findings.
Imaging at the standard oncology protocol acquisition
time outperformed delayed imaging both in visual and
semi-quantitative analysis.
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